Ryan O’Keefe: Exploring Gaucher’s Disease
Ryan O’Keefe, Internal Medicine Resident at the Hospital of The University of Pennsylvania, Creator of Point of Care Medicine, shared a post on X:
“Gaucher’s Disease
Gaucher’s disease is the most common lysosomal storage disorder, caused by a deficiency of the enzyme glucocerebrosidase (GBA).
This leads to the accumulation of its substrate, glucocerebroside, within the lysosomes of macrophages, forming ‘Gaucher cells.’
These lipid-laden cells infiltrate various organs, leading to a variable clinical picture that often mimics rheum, heme, and infectious diseases.
Hepatosplenomegaly is a classic finding due to the infiltration of Gaucher cells in the reticuloendothelial system.
Bone pain, lytic lesions, pathologic fractures, and avascular necrosis are common.
Anemia and thrombocytopenia are frequent due to bone marrow infiltration and hypersplenism.
Gaucher’s disease confers a significantly increased lifetime risk of hematologic malignancies, particularly multiple myeloma and other gammopathies.
Patients require lifelong screening with SPEP, UPEP, and serum free light chains.
The chronic inflammation can manifest as fever, arthritis, and marked hyperferritinemia, mimicking adult-onset Still’s disease.
Source: CPS – April 25, 2026 Simplicity in Complexity – rheumatoid arthritis in the setting of a febrile illness”
Stay updated with Hemostasis Today.
-
Sep 29, 2026, 19:00Caitlin Raymond: Can Artificial Blood Solve Blood Supply Shortages?
-
Sep 29, 2026, 18:51Chaza Alaji: Dyslipidemia, Thrombosis and the DIC Diagnostic Trap
-
Sep 29, 2026, 17:31Rajnikant Patel: Bridging Ayurvedic Concepts and Modern Toxin-Mediated Disease
-
Sep 29, 2026, 17:13Nicholas LangÖ‰ A Meaningful Case of Immune Thrombocytopenia
-
Sep 29, 2026, 16:55Ayatullah Gamal Wahab: When the CBC Lies
-
Sep 29, 2026, 16:35Jonathan Douxfils: Navigating the VTE Risk Continuum in Reproductive Medicine
-
Sep 29, 2026, 16:35Chaima Rajeh: Types of Anemia and Their Laboratory Features
-
Sep 29, 2026, 16:27Scott Isaacs: How GLP-1 RAs Target Systemic Inflammation to Drive Cardio, Autoimmune, and Gut Health
-
Sep 29, 2026, 16:21Yitshak Kreiss: From Treating Patients to Defining the Standard of Knowledge